147 related articles for article (PubMed ID: 7166599)
41. Regulation of vasopressin secretion in a patient with chronic hypernatraemia.
Smitz S; Legros JJ
Acta Endocrinol (Copenh); 1985 Nov; 110(3):346-51. PubMed ID: 4072575
[TBL] [Abstract][Full Text] [Related]
42. Radioimmunoassay of (8-arginine)-vasopressin. I. Methodology.
Czernichow P; Merkelbach U; Vallotton MB
Acta Endocrinol (Copenh); 1975 Nov; 80(3):444-52. PubMed ID: 1242561
[TBL] [Abstract][Full Text] [Related]
43. Radioimmunoassay of arginine-vasopressin in human urine and its use in physiological and pathological states.
Khokhar AM; Ramage CM; Slater JD
J Endocrinol; 1978 Dec; 79(3):375-89. PubMed ID: 744931
[TBL] [Abstract][Full Text] [Related]
44. Simultaneous radioimmunoassay for plasma arginine-vasopressin and oxytocin using DEAE Sephadex A 25 extraction.
Chiodera P; Louis F; Legros JJ
J Endocrinol Invest; 1984 Aug; 7(4):287-93. PubMed ID: 6501802
[TBL] [Abstract][Full Text] [Related]
45. Osmotic and non-osmotic regulation of thirst and vasopressin secretion in patients with compulsive water drinking.
Thompson CJ; Edwards CR; Baylis PH
Clin Endocrinol (Oxf); 1991 Sep; 35(3):221-8. PubMed ID: 1742879
[TBL] [Abstract][Full Text] [Related]
46. [Radioimmunoassay of vasopressin in unextracted random urine; clinical application for screening of central diabetes insipidus].
Kondo K; Otake K; Iwasaki Y; Oiso Y; Takatsuki K
Nihon Naibunpi Gakkai Zasshi; 1989 May; 65(5):537-48. PubMed ID: 2776922
[TBL] [Abstract][Full Text] [Related]
47. Hormonal and cardiovascular responses to DDAVP in man.
Williams TD; Lightman SL; Leadbeater MJ
Clin Endocrinol (Oxf); 1986 Jan; 24(1):89-96. PubMed ID: 3519005
[TBL] [Abstract][Full Text] [Related]
48. Effects of acute water load, hypertonic saline infusion, and furosemide administration on atrial natriuretic peptide and vasopressin release in humans.
Kimura T; Abe K; Ota K; Omata K; Shoji M; Kudo K; Matsui K; Inoue M; Yasujima M; Yoshinaga K
J Clin Endocrinol Metab; 1986 May; 62(5):1003-10. PubMed ID: 2937798
[TBL] [Abstract][Full Text] [Related]
49. Close association of urinary excretion of aquaporin-2 with appropriate and inappropriate arginine vasopressin-dependent antidiuresis in hyponatremia in elderly subjects.
Ishikawa Se ; Saito T; Fukagawa A; Higashiyama M; Nakamura T; Kusaka I; Nagasaka S; Honda K; Saito T
J Clin Endocrinol Metab; 2001 Apr; 86(4):1665-71. PubMed ID: 11297601
[TBL] [Abstract][Full Text] [Related]
50. A new radioimmunoassay for human alpha atrial natriuretic peptide and its physiological validation.
Burrell LM; Palmer J; Charlton JA; Thomas T; Baylis PH
J Immunoassay; 1990; 11(2):159-75. PubMed ID: 2140837
[TBL] [Abstract][Full Text] [Related]
51. Osmoregulation of arginine-8-vasopressin secretion in primary hypothyroidism and in Addison's disease.
Laczi F; Janáky T; Iványi T; Julesz J; László FA
Acta Endocrinol (Copenh); 1987 Mar; 114(3):389-95. PubMed ID: 3564840
[TBL] [Abstract][Full Text] [Related]
52. Radioimmunoassay for arginine-vasopressin in cold ethanol extracts of plasma.
Camps J; Martínez-Vea A; Pérez-Ayuso RM; Arroyo V; Gaya JM; Rivera-Fillat F
Clin Chem; 1983 May; 29(5):882-4. PubMed ID: 6839473
[TBL] [Abstract][Full Text] [Related]
53. Carbamazepine diminishes the sensitivity of the plasma arginine vasopressin response to osmotic stimulation.
Gold PW; Robertson GL; Ballenger JC; Kaye W; Chen J; Rubinow DR; Goodwin FK; Post RM
J Clin Endocrinol Metab; 1983 Nov; 57(5):952-7. PubMed ID: 6619270
[TBL] [Abstract][Full Text] [Related]
54. Chronic hypernatremia derived from hypothalamic dysfunction: impaired secretion of arginine vasopressin and enhanced renal water handling.
Fukagawa A; Ishikawa SE; Saito T; Kusaka I; Nakamura T; Higashiyama M; Nagasaka S; Kusaka G; Masuzawa T; Saito T
Endocr J; 2001 Apr; 48(2):233-9. PubMed ID: 11456273
[TBL] [Abstract][Full Text] [Related]
55. Antidiuretic and PGE2 responses to AVP and dDAVP in subjects with central and nephrogenic diabetes insipidus.
Moses AM; Scheinman SJ; Schroeder ET
Am J Physiol; 1985 Mar; 248(3 Pt 2):F354-9. PubMed ID: 3856399
[TBL] [Abstract][Full Text] [Related]
56. The cardiovascular effect of vasopressin in relation to its plasma concentration in man and its relevance to high blood pressure.
Khokhar AM; Slater JD; Ma J; Ramage CM
Clin Endocrinol (Oxf); 1980 Sep; 13(3):259-66. PubMed ID: 7214720
[TBL] [Abstract][Full Text] [Related]
57. [Radioimmunological assay of plasma arginine-vasopressin in man. Comparison of 2 methods of extraction].
Wolf JP; Dumoulin G; Henriet MT; Baulay A; Berthelay S
Pathol Biol (Paris); 1987 Apr; 35(4):422-6. PubMed ID: 3295707
[TBL] [Abstract][Full Text] [Related]
58. Selective osmoreceptor dysfunction in the syndrome of chronic hypernatremia.
Halter JB; Goldberg AP; Robertson GL; Porte D
J Clin Endocrinol Metab; 1977 Apr; 44(4):609-16. PubMed ID: 849975
[TBL] [Abstract][Full Text] [Related]
59. Two families with hereditary diabetes insipidus not due to osmoreceptor failure.
Laczi F; Julesz J; Vecsernyés M; Halász Z; Márk G; Ovári Z; Szarvas F
Horm Metab Res; 1992 Feb; 24(2):70-2. PubMed ID: 1572598
[TBL] [Abstract][Full Text] [Related]
60. A practical proposal for arginine-vasopressin radioimmunoassay.
Moulin MA; Camsonne R; Bigot MC; Debruyne D
Clin Chim Acta; 1978 Sep; 88(2):363-74. PubMed ID: 699331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
